Henry Skinner

Henry Skinner is CEO of the AMR Action Fund, a mission-driven fund financing the development of antimicrobials, and is a leading voice for reforms to address the global AMR crisis. He earned a PhD in Microbiology and MS in Biochemistry from the University of Illinois, postdoctoral training at Baylor College of Medicine, an MS in Bioethics from Harvard Medical School, an MJur in Health Law, Policy, and Management from Texas A&M, and an MS and BS in Biology/Biotechnology from Worcester Polytechnic Institute.